
    
      Patients have echo, blood draw, and QoL survey prior to CART infusion, then 2 days, 1 week, 1
      month and 6 months following CART infusion. If patients experiences CRS, study team acquires
      echo within 72 hours of onset. As part of an optional substudy, patients wear an event
      monitor for 10 days, starting day of CART infusion.
    
  